CAC40: in red, penalized by the bond compartment


(CercleFinance.com) – The Paris Stock Exchange ended this last session of the week with a decline of 1.26%, to 7340 points, penalized by the sharp declines of Teleperformance (-4.2%), Stellantis (-3, 4%), or STMicro (-3%) as well as the context of soaring bond rates.

Over the past week, the Parisian index is content to glean 0.4% and signs an increase of nearly 13.5% since the beginning of the year.

In this summer period, and as the earnings season draws to a close, investors have been paying close attention to two statistics published today in the United States.

The markets thus took note of the slight increase in producer prices on the other side of the Atlantic, which rose slightly in July compared to the previous month, by 0.3% in raw data and 0.2% excluding food, energy and business services.

Over the last twelve months, the rise in producer prices stood at 0.8% in raw data in July and 2.7% excluding food, energy and commercial services, after annual rates of 0.2% and 2.7% observed in June.

Moreover, the morale of American households deteriorated in August, according to the first results of the monthly survey conducted by the University of Michigan.

The confidence index fell to 71.2 this month, against 71.6 last month, while economists expected it to rise around 72.6.

This weekend is mainly marked by the surge in bond rates which penalizes the equity market. Government bonds thus continued to soar, with a yield on ten-year Treasuries reaching 4.15%, a 10-year German bond at 2.62% and OATs at 3.15%.

This increase logically serves the equity market, neglected by investors looking for more attractive yields on bonds.

In the news of French companies, Teleperformance announced on Friday the launch of its takeover bid to acquire the Luxembourg group Majorel, a transaction that it had initially unveiled last April.

Atos (-4.3%) continues its complicated sequence on the stock market this Friday following the decision of the agency S&P Global Ratings to place its rating under review with negative implications.

Genfit announces the publication of new data showing that the clinical performance of its NIS2+ was superior to other tests for the diagnosis of at-risk non-alcoholic steatohepatitis (NASH) in patients aged 65 and over.

Finally, Blue Solutions, the electric battery subsidiary of the Bolloré group, announces that it has entered into a framework contract with the Switzerland Innovation Park Biel/Bienne (SIPBB), a private Swiss non-profit organization that conducts and supports R&D applied to industry.

Copyright © 2023 CercleFinance.com. All rights reserved.

Did you like this article ? Share it with your friends with the buttons below.


Twitter


Facebook


LinkedIn


E-mail





Source link -85